Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Philadelphia Rx Fraud Investigations Have New Chief; Are SEC Cases Next?

Executive Summary

The Philadelphia U.S. Attorney's selection of Virginia Gibson to succeed Jim Sheehan as its Civil Division chief suggests continuity in the office's prescription drug fraud and kickback investigations

You may also be interested in...



Medco SEC Filing For Spin-Off Included “False Statement” On Audit – DoJ Suit

Medco's disclosure of record-keeping problems discovered at its Dallas/Fort Worth pharmacy in an SEC filing included a "false statement," the Philadelphia U.S. Attorney alleges in a complaint filed against the pharmacy benefit management company Sept. 29

Medco SEC Filing For Spin-Off Included “False Statement” On Audit – DoJ Suit

Medco's disclosure of record-keeping problems discovered at its Dallas/Fort Worth pharmacy in an SEC filing included a "false statement," the Philadelphia U.S. Attorney alleges in a complaint filed against the pharmacy benefit management company Sept. 29

Compliance Officers Make Good “Whistleblowers” – U.S. Prosecutor Sheehan

Corporate compliance officers will make up the next wave of "whistleblowers" in health care fraud cases, Philadelphia Associate U.S. Attorney James Sheehan said at the Food & Drug Law Institute Enforcement & Litigation Conference in Washington, D.C. Sept. 22

Related Content

UsernamePublicRestriction

Register

PS040518

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel